4DMedical set for Monday ASX open after TGA nod and end-of-week slide
4DMedical Ltd opens the week with a mixed message for investors. The company got Australian regulatory approval for its CT:VQ lung-imaging software, but the shares dropped after the news. The stock ended Friday at A$4.16, off 8.97%. The S&P/ASX 200 inched up 0.18% to 8,764.2. The index was down 0.73% for the week, ABC said. Friday's session saw busy trading with 12.24 million shares changing hands, or 30.1% of the past week’s volume and 1.7 times the average for Monday through Thursday, data from Morningstar via Motley Fool show. 4DMedical ended the day down 8.4% compared to last Friday’s A$4.54 finish.